Yisen Meng

Peking University

Papers

2

Total Citations

22

H-Index

2

About

Dr. Yisen Meng is a rising leader in urological surgery and surgical robotics, whose work is shaping the future of minimally invasive prostate care. His primary research focuses on the comparative effectiveness of robotic surgical systems and the optimization of endoscopic techniques for benign prostatic hyperplasia. Dr. Meng’s most impactful contribution is his landmark prospective, double-center, randomized controlled trial (2024), which directly compared the novel KangDuo surgical system against the established da Vinci Si system for robot-assisted radical prostatectomy. Garnering 20 citations, this study provides critical evidence on the safety and feasibility of emerging robotic platforms, potentially broadening access to advanced surgery. Additionally, his bibliometric analysis (2025) has mapped the evolving landscape of endoscopic enucleation of the prostate, identifying key research hotspots and guiding future clinical inquiry. By rigorously evaluating both cutting-edge technology and established procedures, Dr. Meng is helping to define best practices and drive innovation in urologic oncology and functional urology, making him a key voice for the next generation of surgical researchers.

Research Focus

Key Achievements

2
H-Index
2
Papers
22
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted Radical Prostatectomy with the KangDuo Surgical System Versus the da Vinci Si System: A Prospective, Double-center, Randomized Controlled Trial
20 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 27
🏛 Institutions: Peking University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago